We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.12B
1-Year Est. Return 67.49%
This Fund
S&P 500
This Quarter Est. Return
+12.58%
1 Year Est. Return
+67.49%
3 Year Est. Return
+215.18%
5 Year Est. Return
+141.46%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$241M
Cap. Flow
+$127M
Cap. Flow %
12.42%
Top 10 Hldgs %
64.32%
Holding
42
New
2
Increased
7
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
KBR icon
KBR
KBR
+$10.2M
2
CZOO
Cazoo Group Ltd
CZOO
+$1.85M
3
VRT icon
Vertiv
VRT
+$1.28M
4
RIVN icon
Rivian
RIVN
+$940K
5
U icon
Unity
U
+$616K

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$32.6M
2
TBPH icon
Theravance Biopharma
TBPH
+$579K
3
TVRD
Tvardi Therapeutics
TVRD
+$5.18K

Sector Composition

Rank Sector Weight
1 Industrials 14.42%
2 Technology 9.67%
3 Consumer Discretionary 5.54%
4 Communication Services 4.68%
5 Consumer Staples 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIVN icon
26
Rivian
RIVN
$24.3B
$8.77M 0.85%
373,632
+50,000
+15% +$940K
U icon
27
Unity
U
$13.3B
$7.85M 0.77%
192,099
+20,000
+12% +$616K
OWL icon
28
Blue Owl Capital
OWL
$6.51B
$6.9M 0.67%
463,251
– –
SLB icon
29
CALL
SLB Ltd
SLB
$78.1B
$6.5M 0.63%
125,000
– –
GRAB icon
30
Grab
GRAB
$13.9B
$4.55M 0.44%
1,351,173
– –
UBER icon
31
Uber
UBER
$138B
$4.23M 0.41%
68,700
– –
LAZR
32
DELISTED
Luminar Technologies
LAZR
$4.04M 0.39%
79,936
– –
TBPH icon
33
Theravance Biopharma
TBPH
$876M
$2.58M 0.25%
229,768
-57,565
-20% -$579K
DAL icon
34
Delta Air Lines
DAL
$57.3B
$2.01M 0.2%
50,000
– –
TVRD
35
Tvardi Therapeutics
TVRD
$23.8M
$1.3M 0.13%
48,670
-125
-0.3% -$5.18K
LAZR
36
CALL
DELISTED
Luminar Technologies
LAZR
$843K 0.08%
16,667
-33,333
-67% -$1.66M
DNA icon
37
Ginkgo Bioworks
DNA
$491M
$741K 0.07%
10,957
– –
CZOO
38
DELISTED
Cazoo Group Ltd
CZOO
$509K 0.05%
+53,568
New +$1.85M
KROS icon
39
Keros Therapeutics
KROS
$204M
$402K 0.04%
10,105
– –
GRABW icon
40
Grab Holdings Warrant
GRABW
$520K
$22.5K ﹤0.01%
100,000
– –
DNA.WS
41
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$10.9K ﹤0.01%
103,521
– –
ATVI
42
DELISTED
Activision Blizzard
ATVI
– –
-347,709
Closed -$32.6M
1
2

Similar funds

CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Chescapmanager's Q4 2023 Portfolio in Review

As of Q4 2023, Chescapmanager held 42 positions worth $1.03B, up 31% from $785M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Chescapmanager deployed $127M of net new capital in Q4 2023, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was Cazoo Group Ltd: 53,568 shares worth $509K.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Theravance Biopharma, an estimated $579K trimmed.

  • Chescapmanager's largest Q4 2023 buy was Cazoo Group Ltd: 53,568 shares worth $509K.
  • Chescapmanager added most to KBR in Q4 2023, an estimated $10.2M increase.
  • Chescapmanager's biggest Q4 2023 reduction was Theravance Biopharma, cutting an estimated $579K.
  • Chescapmanager fully exited Activision Blizzard in Q4 2023, selling an estimated $32.6M.
  • Chescapmanager's ten largest holdings make up 64% of its $1.03B portfolio in Q4 2023.
  • Chescapmanager opened 2 new positions and closed 1 in Q4 2023.
  • Chescapmanager's portfolio value rose 31% quarter-over-quarter to $1.03B.

Based on Chescapmanager's 13F filing for Q4 2023, filed 14 Feb 2024.